According to the research report titled ‘Global Breast Implant Market 2022-2028’, available with MarketStudyReport, global breast implant market generated revenues worth USD 1,588 in 2021 and is slated to develop at 4.7% CAGR during 2022-2028, reaching a valuation of USD 2,190 million by the end of forecast period.

Soaring incidences of breast cancer, combined with growing preference among women for breast augmentation & reconstruction for cosmetic enhancement are variables contributing to global breast implant market expansion. 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5042673/  

For those uninitiated, breast implants are prosthetics (artificial devices) that are used to alter the size, form, and contour of a person's breast.

Availability of a variety of implants based on texture, shape, and size, in consort with rising popularity of cosmetic tourism are catalyzing the industry growth.

The report offers in-depth analysis into the current market situation, as well as the most recent medical technology developments. It provides a unique perspective on degree of competition, market size, growth rate, and key trends. The implications of the COVID-19 crisis on the business landscape are also examined in this study.

Based on product type, worldwide breast implant market is split into saline breast implants and silicone breast implants. In terms of shape, the industry is categorized into anatomical and round. With respect to texture, the marketplace is divided into textured and smooth. Considering application scope, the business sphere is segregated into cosmetic surgery and reconstructive surgery. For end-user ambit, the industry is classified into cosmetology clinics, hospitals, and others. 

For the purpose of better comprehension, the report analyses various regions including North America, Asia Pacific, and Europe to understand the key opportunities for investment as well as to gauge the geographies responsible for optimizing the revenue for the market.

The notable companies that are a part of the competitive hierarchy of worldwide breast implant industry include Sientra Inc., Allergan plc, Guangzhou Wanhe Plastic Materials Co. Ltd., Shanghai Kangning Medical Device Co. Ltd., CEREPLAS Inc., Groupe SEBBIN SAS, Polytech Health & Aesthetics GmbH, Establishment Labs Holdings Inc., Laboratoires Arion, GC Aesthetics plc, Johnson & Johnson, Ideal Implant Inc., and HansBiomed Co. Ltd. among others.